TuHURA Biosciences, Inc. held $3.6M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 3 fiscal years, from 2023 to 2025, and the quarters TuHURA Biosciences, Inc. has filed alongside them.
Ticker history: KTRA became HURA (TuHURA Biosciences, Inc.) on . Earlier news and filings retain their original names and dates. View KTRA history.
Annual figures, oldest first. Point at a bar to read its period.
HURA Debt & Cash by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
HURA Debt & Cash by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More TuHURA Biosciences, Inc. financials
Frequently Asked Questions
TuHURA Biosciences, Inc. held $3.6M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
TuHURA Biosciences, Inc. (HURA) reported $9.2M in long-term debt in Q3 2026.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what TuHURA Biosciences, Inc. (HURA) reported on that line in every period on record.